Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Advanced breast cancer: a phase II trial with gemcitabineJ Carmichael, K Possinger, P Phillip, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Feasibility of dose-intensified paclitaxel after chemotherapy-induced renal insufficiency in a patient with renal transplantationD Lüftner, B Flath, C Akrivakis, et al.
Annals of Hematology|December 2, 2000
Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myelomaO Sezer, K Niemöller, J Eucker, et al.
Anticancer Research|May 1, 2001
Tumor type M2 pyruvate kinase expression in advanced breast cancerD Lüftner, J Mesterharm, C Akrivakis, et al.
Annals of Hematology|December 6, 2001
Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myelomaO Sezer, K Niemöller, C Jakob, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Annals of Hematology|December 29, 2000
Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuriaH Harder, J Eucker, C Zang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantationO Sezer, K Possinger, B Metzner, et al.
Anticancer Research|July 22, 2005
PINP as serum marker of metastatic spread to the bone in breast cancer patientsD Lüftner, D Jozereau, S Schildhauer, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Advanced breast cancer: a phase II trial with gemcitabineJ Carmichael, K Possinger, P Phillip, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Feasibility of dose-intensified paclitaxel after chemotherapy-induced renal insufficiency in a patient with renal transplantationD Lüftner, B Flath, C Akrivakis, et al.
Annals of Hematology|December 2, 2000
Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myelomaO Sezer, K Niemöller, J Eucker, et al.
Anticancer Research|May 1, 2001
Tumor type M2 pyruvate kinase expression in advanced breast cancerD Lüftner, J Mesterharm, C Akrivakis, et al.
Annals of Hematology|December 6, 2001
Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myelomaO Sezer, K Niemöller, C Jakob, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Annals of Hematology|December 29, 2000
Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuriaH Harder, J Eucker, C Zang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantationO Sezer, K Possinger, B Metzner, et al.
Anticancer Research|July 22, 2005
PINP as serum marker of metastatic spread to the bone in breast cancer patientsD Lüftner, D Jozereau, S Schildhauer, et al.
Pageof 17